Enable job alerts via email!
A leading clinical research organization is seeking a full-time Associate Clinical Trial Manager to join their Clinical Trial Management team in Greater London. Ideal for recent PhD graduates, this role offers the chance to develop skills in clinical project administration and management in an international environment, with comprehensive training and a focus on radiopharmaceuticals.
Medpace is currently seeking candidates with PhDs and/or Post-Doctoral Research experience in nuclear medicine, medical physics, medical imaging / radiopharmaceuticals or / radiation oncology for a full-time, office-based Associate Clinical Trial Manager (aCTM) to join our Clinical Trial Management team. The aCTM will work with Project Coordinators and Clinical Trial Managers in performance of clinical trial management activities. Candidate must have a desire to transfer and apply analytical and academic skills in clinical project administration and management. A fantastic opportunity for recent PhD graduates to enter the industry, receive solid foundational training, work in an international environment, and develop their career in the research and development of cutting-edge radiopharmaceuticals (molecular radiotherapy, radiotheranostics, targeted radionuclide therapy). Candidates should expect to have an intensive training period and show the desire and aptitude for an accelerated career path into Clinical Trial Management (CTM).
Medpace is a full-service clinical contract research organisation (CRO). We provide Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Our mission is to accelerate the global development of safe and effective medical therapeutics through its scientific and disciplined approach. We leverage local regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system, anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, employing more than 5,000 people across 40+ countries.